Centric Health Corp. (TSE:CRX – Free Report) – Equities research analysts at Bloom Burton dropped their FY2024 EPS estimates for shares of Centric Health in a note issued to investors on Monday, November 11th. Bloom Burton analyst D. Martin now forecasts that the company will post earnings of ($0.04) per share for the year, down from their previous estimate of ($0.01).
Other equities analysts have also issued research reports about the company. Stifel Canada lowered Centric Health from a “strong-buy” rating to a “hold” rating in a research note on Monday, August 12th. Ventum Cap Mkts upgraded Centric Health to a “strong-buy” rating in a research report on Thursday, August 8th.
Centric Health Stock Performance
Read More
- Five stocks we like better than Centric Health
- Top Stocks Investing in 5G Technology
- Shopify Stock Rally Continues: Why the Growth Story Isn’t Over
- Learn Technical Analysis Skills to Master the Stock Market
- Tariff Troubles: 3 Stocks Planning Higher Prices
- Using the MarketBeat Stock Split Calculator
- Mercer Near Rock Bottom: Is This High-Yield Play Set to Soar?
Receive News & Ratings for Centric Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centric Health and related companies with MarketBeat.com's FREE daily email newsletter.
